Brand

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. Recalls

4 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd..

4Total Recalls
0Critical
108,192Units Affected
Apr 9, 2024Most Recent
All Recalls

Every Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. Recall

Sorted by most recent. Click any recall for full details.

4 recalls
RecallFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-009-13
Oral Drugs·0 affected·Apr 9, 2024
Medium RiskFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-007-13
Oral Drugs·108,192 affected·Apr 9, 2024
RecallFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95)...
Oral Drugs·0 affected·Apr 9, 2024
RecallFDA
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Abilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical, Inc., NDC 59148-011-13
Oral Drugs·0 affected·Apr 9, 2024